Reply

Affiliations

¹ Division of Gastroenterology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
² Division of Gastroenterology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center of Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, Philadelphia, Pennsylvania.

Comment

Nabeel Khan et al. Gastroenterology. 2021 Apr.

. 2021 Apr;160(5):1904.

doi: 10.1053/j.gastro.2021.01.011. Epub 2021 Jan 13.

¹ Division of Gastroenterology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
² Division of Gastroenterology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center of Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, Philadelphia, Pennsylvania.

No abstract available

Comment in

Reply.
Singh S, Khan A. Singh S, et al. Gastroenterology. 2021 Apr;160(5):1895-1896. doi: 10.1053/j.gastro.2021.01.015. Epub 2021 Jan 13. Gastroenterology. 2021. PMID: 33453227 Free PMC article. No abstract available.

The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
Barberio B, Zingone F, Bertani L, Savarino E. Barberio B, et al. Gastroenterology. 2021 Apr;160(5):1903-1904. doi: 10.1053/j.gastro.2020.07.017. Epub 2020 Jul 17. Gastroenterology. 2021. PMID: 32687929 Free PMC article. No abstract available.
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment?
Barberio B, Buda A, Savarino EV. Barberio B, et al. Gastroenterology. 2021 Jun;160(7):2626-2627. doi: 10.1053/j.gastro.2020.08.049. Epub 2020 Aug 30. Gastroenterology. 2021. PMID: 32877708 Free PMC article. No abstract available.